ARCHIVES

In Brief: Hellman to Leave Memorial This Fall For Position As Dean, Vice President at Univ. Of Chicago

This article is from The Cancer Letter archive.

Vol. 14 No. 15 | April 8, 1988

Download PDF Visit The Full Archive

Related Articles

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

NTP Board Approves Concept For New Mutagenesis Assays

January 1, 1988

House approves $210 million for Dept. of Defense cancer research programs.

June 24, 2005

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

NCAB Settles New Touchy PDQ Issues

June 7, 1985